FHL2 switches MITF from activator to repressor of Erbin expression during cardiac hypertrophy

BACKGROUND: Congestive heart failure (CHF) is a significant health care burden in developed countries. However, the molecular events leading from cardiac hypertrophy to CHF are unclear and preventive therapeutic approaches are limited. We have previously described that microphthalmia-associated tran...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cardiol
Main Authors: Rachmin, Inbal, Amsalem, Eden, Golomb, Eliahu, Beeri, Ronen, Gilon, Dan, Fang, Pengfei, Nechushtan, Hovav, Kay, Gillian, Guo, Min, Yiqing, Peter Li, Foo, Roger S-Y, Fisher, David E., Razin, Ehud, Tshori, Sagi
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4478144/
https://ncbi.nlm.nih.gov/pubmed/26025865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcard.2015.05.108
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados